Nagarjun Rangaraj

767 total citations
18 papers, 599 citations indexed

About

Nagarjun Rangaraj is a scholar working on Pharmaceutical Science, Molecular Biology and Pharmacology. According to data from OpenAlex, Nagarjun Rangaraj has authored 18 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Nagarjun Rangaraj's work include Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (5 papers) and Advancements in Transdermal Drug Delivery (4 papers). Nagarjun Rangaraj is often cited by papers focused on Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (5 papers) and Advancements in Transdermal Drug Delivery (4 papers). Nagarjun Rangaraj collaborates with scholars based in India, United States and Finland. Nagarjun Rangaraj's co-authors include Sunitha Sampathi, Saurabh Shah, Saurabh Srivastava, Kritika Laxmikeshav, Sonia Gera, Shashi Bala Singh, Kalpesh Vaghasiya, Swati Jaiswal, Abhisheak Sharma and Jawahar Lal and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Pharmaceutics.

In The Last Decade

Nagarjun Rangaraj

18 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nagarjun Rangaraj India 14 245 152 141 78 58 18 599
Sunitha Sampathi India 16 315 1.3× 190 1.3× 193 1.4× 109 1.4× 40 0.7× 37 734
Popat Kumbhar India 14 166 0.7× 194 1.3× 134 1.0× 87 1.1× 35 0.6× 60 645
Kwan Hyung Cho South Korea 18 377 1.5× 169 1.1× 150 1.1× 90 1.2× 64 1.1× 64 828
Liangxing Tu China 12 218 0.9× 132 0.9× 152 1.1× 50 0.6× 35 0.6× 29 498
Ahmed R. Gardouh Egypt 13 390 1.6× 171 1.1× 134 1.0× 62 0.8× 44 0.8× 41 703
Hany M. Ibrahim Egypt 15 453 1.8× 169 1.1× 130 0.9× 48 0.6× 75 1.3× 19 725
Wensheng Zheng China 16 233 1.0× 288 1.9× 126 0.9× 82 1.1× 76 1.3× 35 752
Akash Chaurasiya India 12 298 1.2× 183 1.2× 140 1.0× 57 0.7× 33 0.6× 24 641
Dong‐Wuk Kim South Korea 12 336 1.4× 94 0.6× 133 0.9× 35 0.4× 77 1.3× 13 547
Deepa Patel India 9 271 1.1× 150 1.0× 102 0.7× 67 0.9× 30 0.5× 18 513

Countries citing papers authored by Nagarjun Rangaraj

Since Specialization
Citations

This map shows the geographic impact of Nagarjun Rangaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nagarjun Rangaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nagarjun Rangaraj more than expected).

Fields of papers citing papers by Nagarjun Rangaraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nagarjun Rangaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nagarjun Rangaraj. The network helps show where Nagarjun Rangaraj may publish in the future.

Co-authorship network of co-authors of Nagarjun Rangaraj

This figure shows the co-authorship network connecting the top 25 collaborators of Nagarjun Rangaraj. A scholar is included among the top collaborators of Nagarjun Rangaraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nagarjun Rangaraj. Nagarjun Rangaraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jain, Harsha, et al.. (2022). Topical delivery of Bruton’s tyrosine kinase inhibitor and curcumin-loaded nanostructured lipid carrier gel: Repurposing strategy for the psoriasis management. Pharmaceutical Development and Technology. 27(9). 975–988. 5 indexed citations
2.
Rangaraj, Nagarjun, Sunitha Sampathi, Vijayabhaskarreddy Junnuthula, et al.. (2022). Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects. Pharmaceutics. 14(9). 1807–1807. 19 indexed citations
3.
Shah, Saurabh, et al.. (2021). Lipid based nanocarriers: A novel paradigm for topical antifungal therapy. Journal of Drug Delivery Science and Technology. 62. 102397–102397. 50 indexed citations
4.
Shah, Saurabh, Nagarjun Rangaraj, Shashi Bala Singh, & Saurabh Srivastava. (2021). Exploring the unexplored avenues of surface charge in nano-medicine. Colloids and Interface Science Communications. 42. 100406–100406. 27 indexed citations
5.
Jain, Harsha, et al.. (2020). Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal. SHILAP Revista de lepidopterología. 2. 100012–100012. 12 indexed citations
6.
Shah, Saurabh, et al.. (2020). Bridging the gap: academia, industry and FDA convergence for nanomaterials. Drug Development and Industrial Pharmacy. 46(11). 1735–1746. 33 indexed citations
7.
Shah, Saurabh, Nagarjun Rangaraj, Kritika Laxmikeshav, & Sunitha Sampathi. (2020). “Nanogels as drug carriers – Introduction, chemical aspects, release mechanisms and potential applications”. International Journal of Pharmaceutics. 581. 119268–119268. 86 indexed citations
8.
Rangaraj, Nagarjun, et al.. (2020). QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach. Drug Delivery and Translational Research. 10(5). 1476–1494. 49 indexed citations
11.
Rangaraj, Nagarjun, et al.. (2019). Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats. DARU Journal of Pharmaceutical Sciences. 27(2). 541–556. 43 indexed citations
12.
13.
Rangaraj, Nagarjun, et al.. (2018). Insight into pulmonary drug delivery: Mechanism of drug deposition to device characterization and regulatory requirements. Pulmonary Pharmacology & Therapeutics. 54. 1–21. 36 indexed citations
14.
Gera, Sonia, et al.. (2017). Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement. AAPS PharmSciTech. 18(8). 3151–3162. 71 indexed citations
15.
Jaiswal, Swati, Mahendra Shukla, Abhisheak Sharma, et al.. (2016). Preclinical pharmacokinetics and ADME characterization of a novel anticancer chalcone, cardamonin. Drug Testing and Analysis. 9(8). 1124–1136. 27 indexed citations
16.
Sharma, Abhisheak, Swati Jaiswal, Mahendra Shukla, et al.. (2015). HPLC–MS-MS Method Development and Validation of Antileishmanial Agent, S010-0269, in Hamster Serum. Journal of Chromatographic Science. 53(9). 1542–1548. 3 indexed citations
17.
Jaiswal, Swati, Abhisheak Sharma, Mahendra Shukla, et al.. (2014). Novel pre-clinical methodologies for pharmacokinetic drug–drug interaction studies: spotlight on “humanized” animal models. Drug Metabolism Reviews. 46(4). 475–493. 30 indexed citations
18.
Rangaraj, Nagarjun, Kalpesh Vaghasiya, Swati Jaiswal, Abhisheak Sharma, & Jawahar Lal. (2014). Do Blood Sampling Sites Affect Pharmacokinetics. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026